• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病治疗管理指南。

Guidelines of care for the management of actinic keratosis.

机构信息

Department of Dermatology, University of California, Davis, Sacramento, California.

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Department of Population Medicine, Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.

DOI:10.1016/j.jaad.2021.02.082
PMID:33820677
Abstract

BACKGROUND

Actinic keratoses (AK) are rough scaly patches that arise on chronically ultraviolet-exposed skin and can progress to keratinocyte carcinoma.

OBJECTIVE

This analysis examined the literature related to the management of AK to provide evidence-based recommendations for treatment. Grading, histologic classification, natural history, risk of progression, and dermatologic surveillance of AKs are also discussed.

METHODS

A multidisciplinary Work Group conducted a systematic review to address 5 clinical questions on the management of AKs and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of the evidence and formulating and grading clinical recommendations. Graded recommendations were voted on to achieve consensus.

RESULTS

Analysis of the evidence resulted in 18 recommendations.

LIMITATIONS

This analysis is based on the best available evidence at the time it was conducted. The pragmatic decision to limit the literature review to English language randomized trials may have excluded data published in other languages or limited identification of relevant long-term follow-up data.

CONCLUSIONS

Strong recommendations are made for using ultraviolet protection, topical imiquimod, topical 5-fluorouracil, and cryosurgery. Conditional recommendations are made for the use of photodynamic therapy and diclofenac for the treatment of AK, both individually and as part of combination therapy regimens.

摘要

背景

光化性角化病(AK)是在慢性紫外线暴露的皮肤上出现的粗糙鳞片斑块,可进展为角质形成细胞癌。

目的

本分析检查了与 AK 治疗相关的文献,为治疗提供了循证建议。还讨论了 AK 的分级、组织学分类、自然史、进展风险和皮肤科监测。

方法

一个多学科工作组进行了系统评价,以解决 5 个关于 AK 管理的临床问题,并应用推荐分级、评估、发展和评估方法评估证据的确定性,并制定和分级临床建议。对分级建议进行了投票,以达成共识。

结果

对证据的分析产生了 18 项建议。

局限性

本分析基于进行时的最佳可用证据。出于将文献综述仅限于英语随机试验的实际考虑,可能排除了以其他语言发表的数据或限制了对相关长期随访数据的识别。

结论

强烈建议使用紫外线防护、局部咪喹莫特、局部 5-氟尿嘧啶和冷冻疗法。对光动力疗法和双氯芬酸治疗 AK 的使用提出了有条件的建议,包括单独使用和作为联合治疗方案的一部分。

相似文献

1
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
2
Guidelines of care for the management of actinic keratosis: Executive summary.光化性角化病管理指南:执行摘要。
J Am Acad Dermatol. 2021 Oct;85(4):945-955. doi: 10.1016/j.jaad.2021.05.056. Epub 2021 Jun 7.
3
Interventions for actinic keratoses.光化性角化病的干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2.
4
Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.长期干预光化性角化病的疗效:系统评价和网络荟萃分析方案。
Syst Rev. 2019 Oct 11;8(1):237. doi: 10.1186/s13643-019-1156-8.
5
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis.评价光化性角化病干预措施的长期清除率:系统评价和网络荟萃分析。
JAMA Dermatol. 2021 Sep 1;157(9):1066-1077. doi: 10.1001/jamadermatol.2021.2779.
6
Treatment of actinic keratosis: a systematic review.光化性角化病的治疗:系统评价。
Arch Dermatol Res. 2023 Jul;315(5):1099-1108. doi: 10.1007/s00403-022-02490-5. Epub 2022 Dec 1.
7
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight.德国真实环境中使用甲基氨基乙酰丙酸的人工日光光动力疗法:非干预性研究ArtLight的结果
Br J Dermatol. 2025 Feb 18;192(3):510-519. doi: 10.1093/bjd/ljae437.
8
Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.布赫尔对使用氨基酮戊酸甲酯乳膏的日光光动力疗法与双氯芬酸加透明质酸凝胶治疗多发性光化性角化病的间接比较。
Eur J Dermatol. 2016 Oct 1;26(5):487-492. doi: 10.1684/ejd.2016.2822.
9
Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review.局部钙泊三醇联合 5-氟尿嘧啶治疗光化性角化病、鲍恩病和鳞状细胞癌:系统评价。
J Cutan Med Surg. 2024 Jul-Aug;28(4):375-380. doi: 10.1177/12034754241256347. Epub 2024 May 23.
10
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe.欧洲面部或头皮光化性角化病治疗相对疗效的网状Meta分析。
PLoS One. 2014 Jun 3;9(6):e96829. doi: 10.1371/journal.pone.0096829. eCollection 2014.

引用本文的文献

1
Real-World Efficacy of Tirbanibulin in Actinic Keratosis Treatment: Expert Consensus and Clinical Insights.替拉瑞林治疗光化性角化病的真实世界疗效:专家共识与临床见解
Dermatol Pract Concept. 2025 Jul 31;15(3):5921. doi: 10.5826/dpc.1503a5921.
2
Awareness, Patient Behaviour, and Treatment Expectations in a French Cohort with Actinic Keratosis (REAKT Survey).法国光化性角化病队列中的认知、患者行为及治疗期望(REAKT调查)
Acta Derm Venereol. 2025 Jul 19;105:adv43351. doi: 10.2340/actadv.v105.43351.
3
Actinic keratosis: comprehensive review of current treatments and emerging therapeutic innovations.

本文引用的文献

1
Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis.三期临床试验研究替比嘧啶软膏治疗光化性角化病。
N Engl J Med. 2021 Feb 11;384(6):512-520. doi: 10.1056/NEJMoa2024040.
2
Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.咪喹莫特 5%乳膏与双氯芬酸 3%凝胶治疗面部或头皮光化性角化病的长期临床疗效:两项随机对照试验的汇总分析。
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):82-89. doi: 10.1111/jdv.15868. Epub 2019 Sep 12.
3
Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients.
光化性角化病:当前治疗方法及新兴治疗创新的全面综述
Postepy Dermatol Alergol. 2025 Jan 31;42(3):221-231. doi: 10.5114/ada.2024.147331. eCollection 2025 Jun.
4
Mendelian randomization study reveals causal association between skin microbiome and skin cancers.孟德尔随机化研究揭示皮肤微生物群与皮肤癌之间的因果关联。
Sci Rep. 2025 Jul 1;15(1):21590. doi: 10.1038/s41598-025-07265-2.
5
Painless PDT using 10% aminolevulinate gel and red light: A pilot clinical trial of short-contact protocols to reduce discomfort during illumination.使用10%氨基乙酰丙酸凝胶和红光的无痛光动力疗法:一项关于短接触方案以减轻光照期间不适的初步临床试验。
Photodiagnosis Photodyn Ther. 2025 Aug;54:104698. doi: 10.1016/j.pdpdt.2025.104698. Epub 2025 Jun 26.
6
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy.光动力疗法治疗光化性角化病中增殖和炎症生物标志物(Ki67、p53和COX-2)的靶向研究
Biomedicines. 2025 Jun 17;13(6):1487. doi: 10.3390/biomedicines13061487.
7
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate.使用氨基乙酰丙酸甲酯的人工日光光动力疗法治疗光老化及美容效果
Acta Derm Venereol. 2025 Apr 22;105:adv43245. doi: 10.2340/actadv.v105.43245.
8
A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp with Red Light Photodynamic Therapy.一项非随机、开放标签、多中心研究,旨在评估10%氨基乙酰丙酸凝胶联合红光光动力疗法对面部和头皮光化性角化病进行扩大野定向治疗的安全性和耐受性。
J Clin Aesthet Dermatol. 2025 Apr;18(4):44-50.
9
Increase in utilization of 5-fluorouracil and imiquimod for actinic keratoses: analysis of US visits from 1995-2019.5-氟尿嘧啶和咪喹莫特用于光化性角化病的使用量增加:对1995年至2019年美国就诊情况的分析
Arch Dermatol Res. 2025 Apr 5;317(1):676. doi: 10.1007/s00403-025-04186-y.
10
Comparative Efficacy and Tolerability of Imiquimod 3.75% Cream vs 5-Fluorouracil 4% cream in the Treatment of Actinic Keratosis: A Split-Face Study.3.75%咪喹莫特乳膏与4%氟尿嘧啶乳膏治疗光化性角化病的疗效和耐受性比较:一项半脸研究
Dermatol Pract Concept. 2025 Jan 30;15(1):4583. doi: 10.5826/dpc.1501a4583.
免疫抑制患者的皮肤鳞状细胞癌。
Curr Oncol Rep. 2019 Jul 29;21(9):82. doi: 10.1007/s11912-019-0831-1.
4
Evaluation of two histological classifications for actinic keratoses - PRO classification scored highest inter-rater reliability.评价两种光化性角化病的组织学分类——PRO 分类的观察者间可靠性得分最高。
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1092-1097. doi: 10.1111/jdv.15580. Epub 2019 Apr 3.
5
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.随机对照临床试验:四种光化性角化病治疗方法的比较
N Engl J Med. 2019 Mar 7;380(10):935-946. doi: 10.1056/NEJMoa1811850.
6
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities.一项针对上肢光化性角化病的氨基酮戊酸光动力疗法的随机、对照、3 期研究。
Dermatol Surg. 2019 Jul;45(7):890-897. doi: 10.1097/DSS.0000000000001760.
7
Thermal Photodynamic Therapy for Actinic Keratoses on Facial Skin: A Proof-of-Concept Study.面部皮肤光化性角化病的热动力光动力疗法:一项概念验证研究。
Dermatol Surg. 2019 Mar;45(3):404-410. doi: 10.1097/DSS.0000000000001702.
8
Conventional versus daylight photodynamic therapy for actinic keratosis: A randomized and prospective study in China.常规与日光光动力疗法治疗光化性角化病:中国一项随机前瞻性研究。
Photodiagnosis Photodyn Ther. 2018 Dec;24:366-371. doi: 10.1016/j.pdpdt.2018.10.010. Epub 2018 Oct 15.
9
Quality of Life, Behaviour and Attitudes towards Actinic Keratosis in Spain: The PIQA Study.西班牙日光性角化病的生活质量、行为及态度:PIQA研究
Actas Dermosifiliogr (Engl Ed). 2018 May;109(4):331-339. doi: 10.1016/j.ad.2018.01.004. Epub 2018 Feb 22.
10
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.氟尿嘧啶 5%乳膏单次疗程用于基底细胞和鳞状细胞癌的化学预防:一项随机临床试验。
JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.